Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Operating Expenses | 1,005 | 654 | 1,205 | 741 | 387 |
| Operating Income | -1,005 | -654 | -1,205 | -741 | -387 |
| Other Income | -21 | -12 | 128 | -1,077 | -3 |
| Pre-tax Income | -1,026 | -666 | -1,076 | -1,818 | -390 |
| Net Income Continuous | -1,026 | -666 | -1,076 | -1,818 | -390 |
| Net Income | $-1,026 | $-666 | $-1,076 | $-1,818 | $-390 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.02 | -0.03 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.02 | -0.03 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,005 | $-654 | $-1,205 | $-741 | $-387 |